KYV-101
855064 - CARTIMMUNE
Phase 1 small_molecule active
Quick answer
KYV-101 for Idiopathic Inflammatory Myopathies is a Phase 1 program (small_molecule) at Kyverna Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kyverna Therapeutics
- Indication
- Idiopathic Inflammatory Myopathies
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active